Chemoinformaics analysis of Diosbulbinoside D
| Molecular Weight | 506.504 | nRot | 4 |
| Heavy Atom Molecular Weight | 476.264 | nRig | 32 |
| Exact Molecular Weight | 506.179 | nRing | 6 |
| Solubility: LogS | -2.212 | nHRing | 4 |
| Solubility: LogP | -0.341 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 66 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 5 |
| nHA | 11 | APOL | 70.5758 |
| nHD | 4 | BPOL | 40.5122 |
| QED | 0.416 |
| Synth | 6.124 |
| Natural Product Likeliness | 2.716 |
| NR-PPAR-gamma | 0.797 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.126 |
| Pgp-sub | 0.992 |
| HIA | 0.679 |
| CACO-2 | -5.602 |
| MDCK | 0.000158072 |
| BBB | 0.175 |
| PPB | 0.565089 |
| VDSS | 0.914 |
| FU | 0.424159 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.033 |
| CYP2c19-inh | 0.006 |
| CYP2c19-sub | 0.136 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.055 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.113 |
| CYP3a4-inh | 0.087 |
| CYP3a4-sub | 0.238 |
| CL | 3.251 |
| T12 | 0.166 |
| hERG | 0.011 |
| Ames | 0.024 |
| ROA | 0.917 |
| SkinSen | 0.031 |
| Carcinogencity | 0.276 |
| EI | 0.006 |
| Respiratory | 0.941 |
| NR-Aromatase | 0.015 |
| Antiviral | Yes |
| Prediction | 0.816217 |